Order Article Reprints

Achzet LM, Astruc-Diaz F, Beske PH, Natale NR, Denton TT, Jackson DA. Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors. Pharmaceutics. 2021; 13(5):636. https://doi.org/10.3390/pharmaceutics13050636

Achzet, Lindsay M., Fanny Astruc-Diaz, Phillip H. Beske, Nicholas R. Natale, Travis T. Denton, and Darrell A. Jackson. 2021. "Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors" Pharmaceutics 13, no. 5: 636. https://doi.org/10.3390/pharmaceutics13050636

Achzet, L. M., Astruc-Diaz, F., Beske, P. H., Natale, N. R., Denton, T. T., & Jackson, D. A. (2021). Liposomal Encapsulated FSC231, a PICK1 Inhibitor, Prevents the Ischemia/Reperfusion-Induced Degradation of GluA2-Containing AMPA Receptors. Pharmaceutics, 13(5), 636. https://doi.org/10.3390/pharmaceutics13050636